Novel software transforms routinely collected MRI, pathology and clinical data into personalized five- and ten-year recurrence risk insight for women with early-stage breast cancer CHICAGO, IL – October 15, 2026 – SimBioSys®, an AI-driven precision medicine company revolutionizing how cancer…
Moderated by Emmy Award-winning host of ABC15’s Sonoran Living Terri Ouellette, the Breast Cancer Awareness Month event will unite leaders in healthcare, AI, investment and patient advocacy to explore how innovation can improve breast cancer care PHOENIX, AZ – September…
Ferrum Health will offer TumorSight® Viz through its Model Hub, helping clinicians integrate AI-driven breast cancer surgical planning into care delivery with greater clarity and confidence CHICAGO, IL – July 23, 2026 – SimBioSys®, an AI-driven precision medicine company revolutionizing…
Company to unveil TumorSight® Viz 1.4 and surgical outcome visualization capability, advancing precision and personalization in breast cancer surgery CHICAGO, IL – April 29, 2026 – SimBioSys®, an AI-driven precision medicine company revolutionizing how cancer is understood and treated, today…
New evidence underscores TumorSight® Viz’s ability to deliver reproducible landmark identification and measurement for early-stage breast cancer surgical planning CHICAGO, IL – March 5, 2026 – SimBioSys®, an AI-driven precision medicine company revolutionizing how cancer is understood and treated, today…
Company strengthens AI and technology leadership as it advances next-generation precision oncology platform CHICAGO, IL – January 27, 2026 – SimBioSys®, an AI-driven precision medicine company revolutionizing how cancer is understood and treated, today announced the appointment of Senthil Periaswamy,…
SOLUTIONS
RESOURCES
©SimBioSys